News

The studies were undertaken at an independent research laboratory in the US with significant experience with visceral Leishmaniasis animal models. Dosages of 10mg/kg and 20mg/kg of iCo-009 were

According to the company, the platform, brand-named ReliArray, can simultaneously screen for four non-human pathogens in animal serum. ReliArray offers specific screening targeted toward the most common non-human

According to the company, Acticoat Flex has been designed to support physicians dealing with injuries at high risk of infection. The dressings utilize the Silcryst nano-crystalline silver technology

According to the report, the US Court of Appeals for the federal circuit has affirmed a previous court’s decision that a patent on the medicine is both valid

InNexus has also announced that it intends to issue 10% unsecured convertible debentures, for maximum proceeds to InNexus of $1.25 million. Each debenture will be convertible into common

Competitive Technologies (CTT) has exclusive worldwide rights to the device, a non-invasive method for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and

Under the terms of the agreement, Sanofi-Aventis Canada owns the rights to develop, manufacture and commercialize civamide cream in Canada along with a second generation cream that is

As part of the collaboration, Critical Path Institute (C-Path), Applied Biosystems, and Asuragen will partner to develop a panel of assays with gene targets determined to be associated

Under the terms of the agreement, Onyx will obtain a worldwide license for BGC 945 and all of its related patents. Onyx will receive exclusive worldwide marketing rights